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INTRODUCTION
House dust mites are an important cause of respiratory aller-
gic disorders and atopic dermatitis.1 Standardization of house 
dust mite extracts is necessary for the production of diagnostic 
and therapeutic agents for allergic diseases. Two species of house 
dust mite, Dermatophagoides farinae and D. pteronyssinus, are 
prevalent in Korea.2 Group 1 and group 2 allergens constitute 
40%-60% of the total allergenicity in house dust mites.3
Unfortunately, mite allergens from geographically different 
regions often show different allergenicities. For example, aller-
gen molecules have various immunoglobulin E (IgE) reactivi-
ties in European countries.4 The differences may be due to ami-
no acid sequence changes in the allergenic proteins. Raw mate-
rial from different mite culture isolates might also have an influ-
ence on the quality of allergen extracts.5 Importantly, commer-
cial mite extracts produced in European countries, which are 
generally used in Korea, have considerable variability in protein 
and major allergen content.6,7 Significant protein heterogeneity 
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and a substantial variability in skin prick test reactivity have been 
described in the literature. In addition, manufacturers use dif-
ferent allergen units to label the allergenic activities of their 
products. This makes it difficult to compare products from dif-
ferent companies.8 The selection of source material for extract 
preparation is a critical factor affecting the quality of allergen 
extracts used for clinical research.
In this study, we prepared standardized house dust mite ex-
tracts from cultured mites that are indigenous to Korea. Contents 
of the major allergens (Der f 1, Der f 2, Der p 1, and Der p 2) were 
compared with standardized products from a company in the 
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Purpose:  House dust mites are the most important cause of respiratory allergy in Korea. Standardization of allergen extracts is essential for im-
proving diagnostics and immunotherapeutics. This study was undertaken to evaluate the allergenicity of standardized house dust mite allergen ex-
tracts from Korean house dust mite isolates.  Methods:  Allergen extracts were prepared from cultured Korean house dust mites (Dermatophagoi-
des farinae and D. pteronyssinus). Allergenic activities of Korean house dust mite extracts were compared to standardized extracts from a company 
in the United States whose allergen concentrations were expressed as Allergy Units (AUs). Specifically, we compared group 1 and 2 major allergens 
using two-site enzyme-linked immunosorbent assay (ELISA) kits and an in vivo intradermal test.  Results:  Major allergen concentrations were 17.0 
μg/mg (5.0 μg/mg of Der f 1 and 12.0 μg/mg of Der f 2) for a D. farinae extract and 24.0 μg/mg (11.6 μg/mg of Der p 1 and 12.4 μg/mg of Der p 2) for 
a D. pteronyssinus extract. Using chloramphenicol (CAP) inhibition assays, AUs were 12.5 AU/μg for a D. farinae extract and 12.8 AU/μg for a D. ptero-
nyssinus extract. Allergenic activities were 3- to 4-fold stronger when assessed by intradermal skin tests for in vivo standardization.  Conclusions: 
Allergen extracts were prepared from Korean house dust mites and the allergenicities of the extracts were estimated using AU measurements. House 
dust mite extracts prepared in this study could be utilized as a reference material, which will be useful for the development of diagnostic and immu-
notherapeutic reagents in Korea.
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United States (US). Allergenic activities were compared with the 
standardized products using in vitro and in vivo methods.
MATERIALS AND METHODS
Allergen extraction
Two species of house dust mites, D. farinae and D. pteronyssi-
nus, which were maintained by the Arthropods of Medical Im-
portance Resource Bank, Yonsei University College of Medicine, 
Seoul, Korea, were used in this study. Mite bodies were collect-
ed by using saturated salt water and were then freeze dried.2 Af-
ter defatting with ethyl ether, allergens were extracted with vari-
ous buffers (with and without 0.2% phenol) as shown in Table 1. 
The extracts were dialyzed against distilled water with or without 
0.2% phenol and freeze-dried. Protein concentrations were de-
termined using Protein Assay kits (Bio-rad, Hercules, CA, USA).
Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) and Western blot analyses
Lyophilized allergen extracts were reconstituted in a solution 
containing 0.9% NaCl, 0.03% human serum albumin, and 50% 
glycerol. The extracts (30 μg each sample/well) were separated 
on a 12% SDS-PAGE gel (Tris-glycine system) under reducing 
conditions. Before separation, 5×SDS sample buffer was add-
ed to each extract and the mixture was heated for 5 minutes in 
boiling water. Gels were stained with Coomassie brilliant blue 
R250.
Western blot analyses were performed for the analysis of group 
2 allergens with monoclonal antibody 2F38. 2F38 was raised 
against recombinant Der f 2 and recognizes both Der f 2 and Der 
p 2.9 Proteins separated by SDS-PAGE were transferred electro-
phoretically onto polyvinylidine difluoride (PVDF) membranes 
(0.45 μm, GE Water & Process Technologies, Trevose, PA, USA). 
PVDF membranes were reacted with hybridoma culture fluid 
and then incubated with 1:2,000 diluted goat anti-mouse IgG 
conjugated with alkaline phosphatase (Sigma-Aldrich, Sydney, 
Australia). Color was developed using nitro blue tetrazolium 
and 3-bromo-4-chloro-5-indolyl-phosphate (Promega, Madi-
son, WI, USA).
In vitro standardization using a chloramphenicol (CAP) 
inhibition assay
Allergen activities in Korean extracts were compared to extracts 
standardized by a US company (HollisterStier Laboratories LLC, 
Spokane, WA, USA) using competitive inhibition CAP assays. 
For inhibition assays, we used pooled sera from five highly atop-
ic patients with D. farinae-specific IgE levels higher than 100 kU/
L. The serum samples (1:4 diluted) were pre-incubated with 
various concentrations (0.001 to 20 μg/mL) of inhibitors. Sub-
sequently, anti-human IgE reactivity was measured by UniCAP 
(Phadia, Uppsala, Sweden) according to the manufacturer’s in-
struction. The percentage of inhibition was calculated as (1-Ai/
A0)×100, where Ai stands for IgE value (kU/mL) with an inhibi-
tor, and A0 stands for IgE value without an inhibitor.
In vivo standardization using an intradermal skin test
In vivo standardization was performed using the Bioequiva-
lent Allergy Unit (BAU) measurement.8 Briefly, allergen extracts 
were diluted in 0.9% NaCl, 0.4% phenol solution. Histamine hy-
drochloride (1 mg/mL) and physiological saline were used as 
positive and negative controls. A 3-fold dilution that induced a 
sum of erythema of 50 mm by the intradermal skin test (ED50) 
was calculated. A five million-fold dilution (the 14th three-fold 
dilution) of 100,000 BAU/mL produced a sum of erythema di-
ameter of 50 mm by intradermal skin testing in highly reactive 
subjects. Allergic subjects (n=15) having D. farinae-specific IgE 
levels higher than 3.5 kU/L were enrolled for this in vivo study.
Measurement of major allergen content (two-site enzyme-
linked immunosorbent assay [ELISA]) and endotoxin
Major allergens, Der f 1, Der p 1, Der f 2, and Der p 2, in the al-
lergen extracts were assessed using two-site ELISA kits (Indoor 
Biotechnologies Inc., Charlottesville, VA, USA). Endotoxin con-
tent was estimated by the QCL-1000 (Lonza, Walkersville, MD, 
USA), which utilizes Limulus Amebocyte Lysate (LAL).
 
RESULTS
Allergen extraction and major allergen content
Total protein and major allergen concentrations in D. farinae 
extracts prepared using four different buffers (pH 4.2-8.5) were 
measured (Table 1). More Der f 1 was detected when buffers had 
a higher pH. Total protein concentration was found to be high-
est in bicarbonate buffer, pH 8.0. The concentration of Der f 2 
was higher in Korean HDM extracts compared to the US stan-
dardized extract. In contrast, group 1 allergens (Der f 1 and Der 
p 1) and Der p 2 were higher in the US standardized extracts 
(Table 2). There was no difference in group 2 allergens based on 
Western blot analysis (Fig. 1B). A putative dimer band of Der f 2 
was detected in D. farinae extracts from the US.
Allergen potency of the extracts measured by CAP inhibition
Korean and US standardized allergen extracts were analyzed 
by SDS-PAGE. The patterns of protein bands separated by SDS-
PAGE were not identical (Fig. 1A). The thick band that resolved 
Table 1.  Allergen extraction using different buffers
Buffer* Protein concentration (μg/mL) Der f 1 (ng/mL)
Borate, pH 4.2 281.4 844.3
Phosphate, pH 7.4 338.0 808.8
Bicarbonate, pH 8.0 433.4 1,145.5
Borate, pH 8.5 367.8 1,623.5
*Proteins were extracted by 1:100 (w/v) of each buffer.
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at 66 kDa might be human serum albumin (HSA). HSA is often 
included in allergen extracts in order to increase protein stabili-
ties. Allergy Units per mL (AU/mL) were determined by in vitro 
comparison to the reference standard. Competitive IgE-binding 
CAP inhibition was performed for in vitro standardization. Ko-
rean standardized D. farinae and D. pteronyssinus extracts were 
able to inhibit 99.9% and 103.8% of allergenicity respectively, 
compared to US standardized extracts (Fig. 2). Korean stan-
dardized D. farinae and D. pteronyssinus extracts had AUs of 
12.5 AU/μg and 12.8 AU/μg, respectively.
Allergen potency of the extracts measured by in vivo 
intradermal tests
Intradermal skin tests were performed for in vivo standardiza-
tion. Bioequivalent Allergy Units per mL (BAU/mL) are based 
on the quantitative skin test. We calculated activities of 39.1 
BAU/μg for D. farinae (ED50=13.99±0.75) and 41.9 BAU/μg for 
D. pteronyssinus (ED50=13.63±1.32). Allergenicity determined 
by in vivo methods exhibited 3- to 4-fold stronger activities 
compared to the activity measured in vitro.
Endotoxin content of house dust mite extracts
Endotoxin levels were determined to be 1,320 EU/mL and 64 
EU/mL in Korean D. farinae and D. pteronyssinus extracts when 
phenol was added during the allergen extraction process (Table 
3). Much lower levels of endotoxin (68.8% for D. farinae and 
3.1% for D. pteronyssinus) were detected compared to those of 
HollisterStier extracts per protein concentration when 0.2% 
phenol was added during allergen extraction. However, lower 
levels of total protein were detected when phenol was added 
during dialysis due to protein precipitation.
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Fig. 1.  SDS-PAGE and Western blot analysis of house dust mite extracts. Aller-
gen extracts were separated on 12% SDS-PAGE gels under reducing conditions 
(A) and probed with a monoclonal antibody raised against recombinant Der f 2 (B).
M, molecular mass standard; KF, D. farinae extract standardized in Korea; UF, D. 
farinae extract standardized in USA; KP, D. pteronyssinus extract standardized 
in Korea; UP, D. pteronyssinus extract standardized in the US.
Table 3.  Endotoxin levels in allergen extracts
Allergen extract Phenol
Protein 
concentration 
(mg/mL)
Endotoxin level
EU/mL EU/mg*
US stan-
dardized
D. farinae + 0.798 3,890 4,875
D. pteron-
yssinus
+ 0.781 2,600 3,329
Korea stan-
dardized
D. farinae - 0.522 8,740 16,743
+ (extraction) 0.394 1,320 3,353
+ (dialysis) 0.221 5,780 26,118
D. pteron-
yssinus
- 0.459 156 340
+ (extraction) 0.630 64 102
+ (dialysis) 0.124 25.6 206
*EU/mg was calculated for endotoxin levels per protein concentration of aller-
gen extract.
Table 2.  Major allergen contents of house dust mite extracts
Allergen extracts Group 1 allergen  (μg/mg)
Group 2 allergen  
(μg/mg)
D. farinae (Korea) 5.0 12.0
D. farinae (US) 12.0 10.4
D. pteronyssinus (Korea) 11.6 12.4
D. pteronyssinus (US) 46.5 27.3
Fig. 2.  In vitro standardization of house dust mite allergen extracts by CAP inhibition. CAP inhibition of standardized Korean and US D. farinae (A) and D. pteronyssi-
nus (B) extracts.
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DISCUSSION
Standardization of house dust mite allergen extracts is essen-
tial for the development and improvement of diagnostic and 
therapeutic agents for house dust mite allergy patients. In Ko-
rea, almost all allergy diagnostics and immunotherapeutics are 
imported. This study may encourage researchers to initiate the 
manufacturing of diagnostic and therapeutic reagents in Korea.
A previous study produced house dust mite extracts using 
phosphate buffered saline. Its allergenic activity was evaluated 
using skin prick tests and intradermal skin tests.11 In this study, 
they achieved 81.0%-84.6% allergenic activity from Korean D. 
farinae and D. pteronyssinus extracts compared to commercial-
ly available skin test reagent extracts. Major allergen concentra-
tions were measured to be 34.6 μg/mg for Der f 1, 17.0 μg/mg 
for Der f 2, 21.0 μg/mg for Der p 1, and 18.6 μg/mg for Der p 2.10
In the present study, bicarbonate buffer was utilized. Bicar-
bonate buffer led to enhanced extraction of allergenic mole-
cules, especially Der f 1 (Table 1). Major allergen concentrations 
were also compared to US standardized extracts (Table 2). Al-
though lower concentrations of major allergens were measured 
by two-site ELISA, the results were not found to be directly pro-
portional to the in vitro allergenic activity assayed by CAP inhi-
bition tests or in vivo assays. Sequence polymorphisms may 
partially explain the differences between the allergen content 
and skin test reactivities.12 It is necessary to investigate the se-
quence polymorphisms of major allergens. The difference in 
extraction procedures may also affect the concentrations of 
major allergens in the extracts. Notably, addition of phenol af-
fected the protein concentration of allergen extracts (Table 3).
Recently, we studied sequence polymorphisms of Der f 1, Der 
p 1, Der f 2, and Der p 2, which may influence quantification, 
by using monoclonal antibody-based two-site ELISA kits.13 In a 
polymorphism study, Der p 2 variants with Asn114, which is re-
sponsible for the strong affinity to the monoclonal antibodies 
1D8 (coating antibody in Indoor two-site ELISA kit) and 4G7 
(detection antibody in indoor two-site ELISA kit) (currently 7A1 
is being used), constitute 76.7% (46/60), and variants with Ser 
at position 47, which may have strong IgE affinity, accounted 
for 83.3% (50/60) from Korean D. pteronyssinus isolate. The 
higher concentration of Der f 2 may be partly explained by de-
creased polymorphisms in antibody binding regions. For exam-
ple, no sequence variation was found at position 114 of Der f 2 
from the Korean house dust mite isolate. The lower levels of de-
tected Der p 1 may have been influenced by the amino acid 
substitution at positions 124 and 182. This amino acid substitu-
tion may influence antibody binding, subsequently leading to 
decreased detection.
The allergenic activity of Korean and US allergen extracts was 
determined to be similar based on in vitro standardization. This 
observation is interesting because we observed some differenc-
es in major allergen content as determined by a commercial 
two-site ELISA kit (Table 2). These results imply that the actual 
concentration of group 1 and 2 allergens may be similar in these 
extracts. Western blot analysis of group 2 allergen using the 
monoclonal antibody 2F38 showed that there are similar con-
centrations of Der f 2 and Der p 2 in each mite extract, although 
there was stronger reactivity to Der f 2 than Der p 2 (Fig. 1B). It 
is also possible that the allergenic components that do not be-
long to group 1 or 2 allergens could contribute to the overall al-
lergenicity of the extracts.
Some components of the allergen extracts are known to influ-
ence immunologic and/or adjuvant activity.14 Chitin and β-
glucan in house dust extracts may aggravate house dust mite al-
lergen-induced allergic inflammation.15 Endotoxin is one of the 
most well characterized immunomodulatory substances con-
tained in mite extracts. Due to the microflora residents in the 
mite gut, endotoxin is present in house dust mite extracts. Ex-
perimental studies have shown that exposure to low levels of 
endotoxin may exacerbate an allergic response; however, expo-
sure to high levels might be protective.16-19 Epidemiologic stud-
ies have also shown that high endotoxin levels prevented the 
development of allergic disease in rural areas populated with 
stable animals. We compared endotoxin levels in Korean and 
US extracts (Table 3). Endotoxin contents measured in the ex-
tracts are within the range of those found in various US stan-
dardized dust mite extracts.20 D. farinae extracts showed relative-
ly high endotoxin concentrations, whereas D. pteronyssinus ex-
tracts contained little endotoxin. This observation is in line with 
a previous report by Trivedi et al., in 2003.20 The difference in 
endotoxin concentration may reflect the different microflora in 
the mite gut. 16S rDNA fragments from multiple bacterial spe-
cies were detected from house dust mite cultures.21 Bartonella 
species are thought to be the main source of endotoxins in house 
dust mite extracts.
These results suggest that researchers should choose the ap-
propriate strain of house dust mite for their research aim. Fur-
ther, removal of endotoxin from extracts may be necessary to 
accurately interpret results. Standardized allergen extracts pro-
duced in this study will be useful for the development of allergy 
diagnostics and immunotherapeutics in Korea.
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